Buscador de Revistas

The Annual Review of Immunology, in publication since 1983, covers the significant developments in the field of immunology.

Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry aims to cover all the latest and outstanding developments in medicinal chemistry and rational drug design for the discovery of new anti-inflammatory & anti-allergy agents.

immunology

Archivum Immunologiae et Therapiae Experimentalis (AITE), founded in 1953 by Ludwik Hirszfeld, is a bimonthly, multidisciplinary journal. It publishes reviews and full original papers dealing with immunology, experimental therapy, immunogenetics, transplantation, microbiology, immunochemistry and ethics in science.Publication Schedule
One volume comprising 6 issues per year Illustrations
Black & white Reprints
20 complimentary reprints per article Bibliographic Data
AITE, Arch. Immunol. Ther. Exp.
First published in 1953
1 volume per year, 6 issues per volume
approx. 420 pages per volume
Format: 21 x 27.9 cm
ISSN 0004-069X (print)
ISSN 1661-4917 (electronic)

Translating research into clinical practice.

Asthma, Translational Research, Respiratory Medicine

Current understanding of autoimmune disease is being increasingly underpinned by the new molecular sciences. Progress in this area has been little short of spectacular, and all clinical specialities now recognise autoimmunity as a major component of the diseases with which they are involved. Autoimmunity is an international, peer reviewed journal that publishes articles of clinical and basic science on the pathogenesis, immunology, genetics, molecular biology, and treatment of autoimmune diseases. In addition to the basic mechanisms and elements of the immune system, the journal focuses on the autoimmune processes associated with systemic lupus erythematosus, rheumatoid arthritis, Sjogren syndrome, diabetes, multiple sclerosis, and other systemic and organ-specific autoimmune diseases. The journal is not restricted to any disease type or clinical speciality, but reflects the areas where scientific progress is most rapid and clinical applications significant and widespread. The journal is valuable to clinicians and researchers in immunology and molecular biology. Read More: http://informahealthcare.com/page/aut/Description.

Autoimmunity Reviews will publish up-to-date, structured reviews on diverse topics in autoimmunity, written by first-class experts in the field. The articles will include demonstrative illustrations and tables and will all have a "take-home" message.Articles will principally be invited by the Editors-in-Chief upon the recommendations of the international Editorial Board, and will cover all fields of autoimmunology, bridging the gap between basic and clinical sciences. Contributions in basic sciences will include those on the pathophysiology and mechanisms of disorders as well as genomics and proteomics; clinical contributions will focus upon the diseases, novel therapies and clinical associations.Benefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services .Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com

Since its inception in 1976, Cancer Immunology, Immunotherapy (CII) has reported significant advances in the field of tumor immunology.  The journal serves as a forum for new concepts and advances in basic, translational, and clinical cancer immunology and immunotherapy. CII is keen to publish broad-ranging ideas and reviews, results which extend or challenge established paradigms, as well as negative studies which fail to reproduce experiments that support current paradigms, and papers that do succeed in reproducing others’ results in different contexts.In addition to publishing original research articles and reviews, CII also offers the following unique publication formats:·         “Focussed Research Reviews,” published together with a conference meeting report, which provide individual speakers with the opportunity to expand on the ideas and concepts they presented at the conference.·         “Symposia-in-Writing,” which are virtual workshops consisting of a series of complime

Cartilage (CART) is a peer-reviewed quarterly journal on the musculoskeletal system with particular attention to cartilage repair, development, function, degeneration, transplantation, and rehabilitation. Aimed at researchers and clinicians involved in cartilage biology and repair, CART publishes full length original manuscripts on all types of cartilage including articular, nasal, auricular, tracheal/bronchial, and intervertebral disc fibrocartilage.

Cellular & Molecular Immunology is a bimonthly journal from the Chinese Society of Immunology and the University of Science and Technology of China. Covering both basic immunology research and clinical applications, Cellular & Molecular Immunology provides the latest information and advancements in our understanding of the immunological response of the host, both in vitro and in vivo.The journal publishes Research Articles, Reviews, Minireviews and Brief Reports in all areas of cellular and molecular immunology, including but not limited to: * clinical immunology * comparative immunology * immunobiology * immunogenetics * immunological techniques * immunopathology * immunopharmacology * infection immunology * neuroimmunology * transplantation immunology * tumor immunology * veterinary immunologyAs China's first English-language immunology journal, Cellular & Molecular Immunology is designed to serve both the Chinese and international communities as a vehicle to rapidly disseminate the latest studies in this field. The journal welcomes submissions that explore novel ideas or un- or contra-orthodox approaches, as long as they are underpinned by conventional scientific practice and present falsifiable hypotheses that are tested with empirical methods and evidence.Manuscripts must provide evidence that can be critically evaluated, and where applicable: * define disorders and clinical symptoms by standard clinical terms (e.g. allergy, asthma, lupus, etc.) * deem results 'significant' only using standard statistical methods in biological effects/outcomes studies * use consistent and defined amounts and mixtures of herbal formulas, or use purified monomer extracts.Terms that may be ambiguous to the broad audience of the journal should be clearly defined within the manuscript.

Clinical & Experimental Allergy strikes an excellent balance between clinical and scientific articles and carries regular reviews and editorials written by leading authorities in their field. In response to the increasing number of quality submissions, since 1996 the journals size has increased by over 30%. Clinical & Experimental Allergy is essential reading for allergy practitioners and research scientists with an interest in allergic diseases and mechanisms. Truly international in appeal, Clinical & Experimental Allergy publishes clinical and experimental observations in disease in all fields of medicine in which allergic hypersensitivity plays a part. Clinical & Experimental Allergy Reviews is a supplement series publishing the edited proceedings of international meetings and sponsored symposia, position papers, guidelines, special reports, and so on. It is allied to Clinical & Experimental Allergy and included with every subscription to the primary research journal.

Clinical & Experimental Immunology is a top ranking, international journal publishing biologically significant studies that have clinical relevance. The Journal is focused on Translational Immunology and is amongst the foremost journals in this field, attracting high-quality papers from all parts of the world. Translation is viewed as a process of applying ideas, insights and discoveries generated through basic scientific studies to the treatment, prevention or diagnosis of human disease. Journal articles cover clinical studies in patients receiving immune-based therapies, in relation to autoimmunity, primary and secondary immunodeficiencies, complement disorders and allergies. The Journal also reports investigations on the pathogenesis of rheumatic, renal and endocrine disorders, as well as infectious diseases, malignancy and transplantation. Basic immunology studies that inform clinical practice or understanding of disease mechanisms are also welcomed, as are studies in non-human model systems and reports on the physiological mechanisms of immunity. In addition to research reports, the Journal publishes highly cited review, perspective and hypothesis articles. These are usually commissioned and published as Translational Mini-Review series, but suggestions to the Editor-in-Chief of topics for such series, or titles for one-off review articles are welcome. The Journal encourages submission of articles that represent position papers on the classification, diagnosis or treatment of immunological disease.Articles deemed to be of potentially high impact may be drawn to the attention of the Editorial Team for allocation to our Fast-Track category, enabling papers of immediate interest to reach their audience as quickly as possible.Free Access in the Developing WorldFree online access to this journal is available within institutions in the developing world through the HINARI initiative with the World Health Organization (WHO).Online OpenAuthors of articles in this journal can now choose to make their articles open access and available free for all readers through the payment of an author fee.